Across TCGA pan-cancer cohorts, FUNDC2P3 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of FUNDC2P3’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where FUNDC2P3 RNA is repressed in tumor relative to normal tissue. In most cancer types FUNDC2P3 is over-expressed in tumor, although a few such as THCA and KIRP show the opposite, repressed pattern.

THCA and KIRP are the cancer types where FUNDC2P3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FUNDC2P3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Female	II,III,IV	−0.043	.033	2	view →
KIRP	Male	II,III,IV	−0.031	.027	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: FUNDC2P3 RNA expression & survival · all FUNDC2P3 data types